These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7426025)

  • 1. Showdomycin and its reactive moiety, maleimide. A comparison in selective toxicity and mechanism of action in vitro.
    Uehara Y; Fisher JM; Rabinovitz M
    Biochem Pharmacol; 1980 Aug; 29(16):2199-204. PubMed ID: 7426025
    [No Abstract]   [Full Text] [Related]  

  • 2. Transport-dependent membrane damage and the irreversible inactivation of nucleoside transport by showdomycin.
    Uehara Y; Rabinovitz M
    Biochem Pharmacol; 1981 Dec; 30(23):3165-9. PubMed ID: 7317101
    [No Abstract]   [Full Text] [Related]  

  • 3. Some chemical and biological characteristics of showdomycin.
    Titani Y; Tsuruta Y
    J Antibiot (Tokyo); 1974 Dec; 27(12):956-62. PubMed ID: 4619627
    [No Abstract]   [Full Text] [Related]  

  • 4. Transport studies of showdomycin, nucleosides and sugars in Escherichia coli B and in showdomycin-resistant mutants.
    Roy-Burman S; Visser DW
    Biochim Biophys Acta; 1972 Sep; 282(1):383-92. PubMed ID: 4560820
    [No Abstract]   [Full Text] [Related]  

  • 5. A showdomycin-resistant mutant of Escherichia coli K-12 with altered nucleoside transport character.
    Komatsu Y; Tanaka K
    Biochim Biophys Acta; 1972 Nov; 288(2):390-403. PubMed ID: 4563236
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the maleimide ring system on the structure-activity relationship of showdomycin.
    Rosenqvist P; Mäkinen JJ; Palmu K; Jokinen J; Prajapati RK; Korhonen HJ; Virta P; Belogurov GA; Metsä-Ketelä M
    Eur J Med Chem; 2022 Jul; 237():114342. PubMed ID: 35439612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Showdomycin analogues: synthesis and antitumor evaluation.
    Numao N; Hemmi H; Naujokaitis SA; Rabinovitz M; Beisler JA
    J Med Chem; 1981 May; 24(5):515-20. PubMed ID: 7241509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity, kinetics, and stoichiometry of sodium-dependent adenosine transport in L1210/AM mouse leukemia cells.
    Dagnino L; Bennett LL; Paterson AR
    J Biol Chem; 1991 Apr; 266(10):6312-7. PubMed ID: 1848853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Showdomycin, a nucleotide-site-directed inhibitor of (Na+ + K+)-ATPase.
    Tobin T; Akera T
    Biochim Biophys Acta; 1975 Apr; 389(1):126-36. PubMed ID: 124587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential competition with cytotoxic agents: an approach to selectivity in cancer chemotherapy.
    Rabinowitz M; Uehara Y; Vistica DT
    Science; 1979 Nov; 206(4422):1085-7. PubMed ID: 493993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxicity of cytosine arabinoside toward murine leukemia L1210 cells and murine bone marrow progenitor cells inhibited in nucleoside transport by cimicifugoside.
    Hemmi H
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):565-8. PubMed ID: 6791252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-D-Ribofluranosyl-1,4-benzoquinone - antibacterial agent with showdomycin-like mode of action.
    Doskocil J; Kalvoda L; Krupicka J
    Biochem Biophys Res Commun; 1975 Jan; 64(3):932-8. PubMed ID: 1096888
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modification of radiation effect by showdomycin on hair roots of the mouse (author's transl)].
    Egawa J; Ishioka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Oct; 34(10):763-8. PubMed ID: 4533784
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of amino acid and sugar transport by showdomycin.
    Roy-Burman S; Huang YH; Visser DW
    Biochem Biophys Res Commun; 1971 Feb; 42(3):445-53. PubMed ID: 5542893
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia.
    Zager RF; Frisby SA; Oliverio VT
    Cancer Res; 1973 Jul; 33(7):1670-6. PubMed ID: 4124487
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycolipid formation in Volvox carteri f. nagariensis: effects of tunicamycin and showdomycin.
    Müller T; Bause E; Jaenicke L
    FEBS Lett; 1981 Jun; 128(2):208-12. PubMed ID: 7262312
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal of inhibiting action of showdomycin on the proliferation of Escherichia coli by nucleosides and thiol compounds.
    Nishimura H; Komatsu Y
    J Antibiot (Tokyo); 1968 Apr; 21(4):250-4. PubMed ID: 4876578
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
    Belt JA
    Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of showdomycin on glycolipid formation. Inhibition of glucosyl-phosphoryl-dolichol in aorta and stimulation of glucosylceramide in yeast.
    Kang MS; Spencer JP; Elbein AD
    J Biol Chem; 1979 Oct; 254(20):10037-43. PubMed ID: 385593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.